Form 4: Colgate-Palmolive Director Receives Stock Grant and Options

Brian Newman, a Director at Colgate-Palmolive, received an annual stock grant and stock options as part of the company's incentive compensation plan.

Summary

• Brian Newman, a Director at Colgate-Palmolive, was granted 2,075 shares of common stock and 2,424 stock options on May 11, 2026.
• The stock grant was valued at $0.0000, indicating it was part of a compensation plan.
• The stock options have an exercise price of $86.74 and become exercisable in three equal annual installments starting May 11, 2027.
• Following these transactions, Newman beneficially owns 7,621 shares of common stock directly and 2,424 shares indirectly through a family trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation and does not provide new financial performance data or strategic shifts.

Positives

• Director compensation through stock grants and options aligns management's interests with shareholders.
• The grant of stock options suggests a belief in future stock price appreciation.
• The vesting schedule for options encourages long-term commitment from the director.

Negatives

• The filing does not contain any negative financial or operational information.

Risks

• The value of the stock options is subject to market fluctuations and the company's future performance.
• Potential for insider trading concerns if transactions are not properly disclosed or timed.

Future Outlook

The stock options granted have an exercise price of $86.74 and will become exercisable in three equal annual installments over three years, starting on the first anniversary of the grant date (May 11, 2027), suggesting an expectation of continued or increased stock value.

Industry Context

StockSavvy.ai notes that the issuance of stock grants and options to directors is a common practice across the consumer staples industry to incentivize performance and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The alignment of director compensation with stock performance can be viewed positively.
• Employees: Standard practice for director compensation, unlikely to have direct impact.

Next Steps

• Stock options become exercisable in installments starting May 11, 2027.

Key Dates

Keywords

Form 4, SEC Filing, Colgate-Palmolive, CL, Director Compensation, Stock Grant, Stock Options, Beneficial Ownership, Insider Trading, Incentive Compensation Plan